Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels.

Knegtering R, Baselmans P, Castelein S, Bosker F, Bruggeman R, van den Bosch RJ

Open source

DOI
10.1176/appi.ajp.162.5.1010
Published
2005 May
Container
The American journal of psychiatry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1176/appi.ajp.162.5.1010,
  title = {Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels.},
  author = {Knegtering R and Baselmans P and Castelein S and Bosker F and Bruggeman R and van den Bosch RJ},
  year = {2005},
  journal = {The American journal of psychiatry},
  doi = {10.1176/appi.ajp.162.5.1010},
  url = {https://doi.org/10.1176/appi.ajp.162.5.1010}
}

RIS

TY  - JOUR
TI  - Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels.
AU  - Knegtering R
AU  - Baselmans P
AU  - Castelein S
AU  - Bosker F
AU  - Bruggeman R
AU  - van den Bosch RJ
PY  - 2005
JO  - The American journal of psychiatry
DO  - 10.1176/appi.ajp.162.5.1010
UR  - https://doi.org/10.1176/appi.ajp.162.5.1010
ER  - 

APA

R, K., P, B., S, C., F, B., R, B., & RJ, V. D. B. (2005). Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels.. The American journal of psychiatry. https://doi.org/10.1176/appi.ajp.162.5.1010

Source records